BioCentury
ARTICLE | Clinical News

Regulated Activation of Prodrugs regulatory update

October 16, 2000 7:00 AM UTC

D-Pharm received U.S. Patent No. 6,077,837 covering prodrugs consisting of an active compound, such as a protein kinase inhibitor, linked to an intracellular transporter by a bond that is preferential...